Physician profile
John A Flatter
NPI 1780071662
$3,218.75
in general payments reported to CMS, 2019-2025
10 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $31.87 · 2022: $51.60 · 2023: $287 · 2024: $2,704 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,596 · Food and Beverage: $1,539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,596.43 |
| Food and Beverage | $1,538.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,438.44 | 2022-2025 | Clareon, Hydrus Microstent, Argos |
| Bausch & Lomb Americas INC. | $1,229.28 | 2023-2024 | Stellaris Elite, Envista Aspire Iol, Teneo |
| Astellas Pharma US INC | $166.82 | 2024 | Izervay |
| Regeneron Healthcare Solutions, INC. | $125.00 | 2024 | Eylea Hd |
| Ocular Therapeutix, INC. | $66.51 | 2024 | Dextenza |
| Rayner Intraocular Lenses Limited | $50.10 | 2024 | Rayone Aspheric, Rayone Spheric, Omidria |
| Abbvie INC. | $48.79 | 2023-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $43.37 | 2024-2025 | Tecnis Iol |
| Rxsight INC | $35.93 | 2020-2024 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Allergan, INC. | $14.51 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Flatter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.